pegfilgrastim-apgf

CHEBI:CHEBI_752453

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2469340
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_category
BLA
marketing_start_date
20201215
package_marketing_start_date
20201215
labeler_name
Pfizer Laboratories Div Pfizer Inc
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
nui
N0000175666
pharm_class_epc
Leukocyte Growth Factor [EPC]
pharm_class
Granulocyte-Macrophage Colony-Stimulating Factor [CS]
pharm_class_pe
Increased Myeloid Cell Production [PE]
pharm_class_cs
Granulocyte Colony-Stimulating Factor [CS]
active_ingredient_name
PEGFILGRASTIM
active_ingredient_strength
6 mg/.6mL
unii
3A58010674
generic_name
pegfilgrastim-apgf
brand_name
NYVEPRIA
brand_name_base
NYVEPRIA
product_ndc
0069-0324
application_number
BLA761111
spl_id
a89f35d2-46e6-457b-a617-3c7537e6f709
package_ndc
0069-0324-01
package_description
1 CARTON in 1 CARTON (0069-0324-01) / 1 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE
spl_set_id
99d30b99-2743-446b-98f3-0430bf4ea869
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class